Examining Mental Health Care Support Amid Insurance Shortcomings
An emergency physician shares a personal tragedy, highlighting the flaws in the U.S. health insurance system regarding mental health treatment.
Entertainment news, movies, and celebrities
An emergency physician shares a personal tragedy, highlighting the flaws in the U.S. health insurance system regarding mental health treatment.
As wildfires blanket U.S. cities in smoke, the soaring asthma cases reveal significant public health challenges linked to climate patterns.
GSK has ceased its efforts to develop a chronic cough therapy, citing the challenges faced during clinical trials.
Drug shortages in the U.S. have surged to 227, while GSK halts development of its chronic cough treatment after disappointing trial results.
The recent U.S. policy on testosterone screenings highlights disparities in access to hormone therapy, notably affecting LGBTQ+ individuals.
Sonothera's ultrasound technology promises treatments for Duchenne muscular dystrophy, but experts remain skeptical amid a lack of clinical data.
MDCalc is enhancing trust in clinical decision-making by implementing a new quality-rating system for its calculators, impacting how physicians use these tools.
The FTC's settlement with CVS Caremark aims to save Americans up to $8.5 billion on insulin by overhauling price manipulation and rebate practices.
Sales under the U.S. drug discount program reached $100 billion in 2025, driven largely by high-cost medications.
Cyclospora infections are at a record high, with Michigan officials pointing to lettuce as a potential source amid an outbreak across multiple states.
Anthropic's Claude Science software targets biopharma research, showcasing AI's positive potential amidst ongoing public skepticism.
Dr. Jeremy Faust, a Boston emergency physician, uses his platform to blend urgent medical insights with broader health discussions, attracting a large audience.
This week's biotech podcast discusses rising health insurance costs and the whistleblower case against an insurer, alongside industry developments.
A significant cyclospora outbreak in Michigan has exceeded 1,000 cases, prompting investigations across several states as health officials seek the source.
A father invests $70 million into developing a gene therapy for his daughter’s rare condition, seeking breakthroughs for patients like her.
Recent research from OpenEvidence questions the effectiveness of large language models in health technology applications, presenting new insights into AI capabilities.
Recent studies suggest that psilocybin therapy may offer enduring relief for patients with depression, presenting a significant advancement in treatment options.
A recent analysis of GLP-1 telehealth platforms reveals significant variation in service quality, highlighting the need for more regulated standards.
Vertex Pharmaceuticals is set to acquire Crinetics Pharmaceuticals for $10 billion, marking a pivotal expansion into rare disease treatments.
Chris Deacon’s tireless efforts led to a $100 million settlement with Horizon Blue Cross Blue Shield, though her contributions remain overshadowed by political figures.